DENTSPLY SIRONA Inc. (NASDAQ:XRAY) issued an update on its FY17 earnings guidance on Friday morning. The company provided EPS guidance of $2.65-2.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.68.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at $64.80 on Friday. DENTSPLY SIRONA Inc. has a 52 week low of $52.53 and a 52 week high of $66.00. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.55 and a current ratio of 2.34. The company has a market cap of $14,871.73, a PE ratio of 25.82, a P/E/G ratio of 2.66 and a beta of 1.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, topping the consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. During the same quarter in the previous year, the firm posted $0.66 earnings per share. DENTSPLY SIRONA’s quarterly revenue was up 5.8% on a year-over-year basis. analysts expect that DENTSPLY SIRONA Inc. will post 2.67 EPS for the current fiscal year.

Several equities research analysts recently commented on XRAY shares. HC Wainwright started coverage on shares of DENTSPLY SIRONA in a research note on Tuesday, July 11th. They set a buy rating and a $74.00 price objective on the stock. Credit Suisse Group reissued an outperform rating and set a $75.00 price objective (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a hold rating to a buy rating and set a $72.00 price objective on the stock in a research note on Thursday, July 13th. BidaskClub lowered shares of DENTSPLY SIRONA from a buy rating to a hold rating in a research note on Wednesday, July 19th. Finally, Stifel Nicolaus reissued a buy rating and set a $66.00 price objective (down previously from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Three analysts have rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company. DENTSPLY SIRONA currently has an average rating of Hold and an average price target of $65.60.

COPYRIGHT VIOLATION NOTICE: “DENTSPLY SIRONA Inc. (XRAY) Issues FY17 Earnings Guidance” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at


DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.